| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327631 | Gynecologic Oncology | 2005 | 7 Pages |
Abstract
Although our findings showed that mdm2 may be used as a prognostic indicator in patients with epithelial ovarian cancer, these results should be supported by more and larger studies.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Erbil Dogan, Ugur Saygili, Burçin Tuna, Mert Gol, Duygu Gürel, Berrin Acar, Meral KoyuncuoÄlu,